IFNG and lung cancer: The results suggest that A‐CpG ODNs suppress the IFN‐γ‐induced expression of PD‐L1 and β2‐MG in human lung cancer by blocking the IFN‐γ receptor and suppressing the phosphorylation of JAK/STAT1, which is regulated by the IFN‐γ signaling pathway.